keyword
https://read.qxmd.com/read/38632387/single-cell-transcriptome-analysis-profiling-lymphatic-invasion-related-tme-in-colorectal-cancer
#21
JOURNAL ARTICLE
Liping Wang, Liming Ma, Zhaona Song, Li Zhou, Kexin Chen, Xizi Wang, Zhen Liu, Baozhong Wang, Chen Shen, Xianchao Guo, Xiaodong Jia
Lymphatic invasion (LI) is extremely aggressive and induces worse prognosis among patients with colorectal cancer (CRC). Thus, it is critical to characterize the cellular and molecular mechanisms underlying LI in order to establish novel and efficacious therapeutic targets that enhance the prognosis of CRC patients. RNA-seq data, clinical and survival information of colon adenocarcinoma (COAD) patients were obtained from the TCGA database. In addition, three scRNA-seq datasets of CRC patients were acquired from the GEO database...
April 17, 2024: Scientific Reports
https://read.qxmd.com/read/38632311/improvement-of-immune-dysregulation-in-individuals-with-long-covid-at-24-months-following-sars-cov-2-infection
#22
JOURNAL ARTICLE
Chansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, Katherine J L Jackson, Daniel B Wilson, Bikash Manandhar, Vera Klemm, Hyon-Xhi Tan, Adam Wheatley, Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mitchell Starr, Phillip Cunningham, Stuart G Turville, Stephen J Kent, Anthony Byrne, Bruce J Brew, David R Darley, Gregory J Dore, Anthony D Kelleher, Gail V Matthews
This study investigates the humoral and cellular immune responses and health-related quality of life measures in individuals with mild to moderate long COVID (LC) compared to age and gender matched recovered COVID-19 controls (MC) over 24 months. LC participants show elevated nucleocapsid IgG levels at 3 months, and higher neutralizing capacity up to 8 months post-infection. Increased spike-specific and nucleocapsid-specific CD4+ T cells, PD-1, and TIM-3 expression on CD4+ and CD8+ T cells were observed at 3 and 8 months, but these differences do not persist at 24 months...
April 17, 2024: Nature Communications
https://read.qxmd.com/read/38632279/inflammation-and-cytomegalovirus-viremia-during-pregnancy-drive-sex-differentiated-differences-in-mortality-and-immune-development-in-hiv-exposed-infants
#23
JOURNAL ARTICLE
Ceri Evans, Kuda Mutasa, Sandra Rukobo, Margaret Govha, Patience Mushayanembwa, Bernard Chasekwa, Florence D Majo, Naume V Tavengwa, Jonathan Broad, Christie Noble, Ethan K Gough, Paul Kelly, Claire D Bourke, Jean H Humphrey, Robert Ntozini, Andrew J Prendergast
Children who are HIV-exposed but uninfected have increased infectious mortality compared to HIV-unexposed children, raising the possibility of immune abnormalities following exposure to maternal viraemia, immune dysfunction, and co-infections during pregnancy. In a secondary analysis of the SHINE trial in rural Zimbabwe we explored biological pathways underlying infant mortality, and maternal factors shaping immune development in HIV-exposed uninfected infants. Maternal inflammation and cytomegalovirus viraemia were independently associated with infant deaths: mortality doubled for each log10 rise in maternal C-reactive protein (adjusted hazard ratio (aHR) 2...
April 17, 2024: Nature Communications
https://read.qxmd.com/read/38632126/effect-of-siponimod-on-lymphocyte-subsets-in-active-secondary-progressive-multiple-sclerosis-and-clinical-implications
#24
JOURNAL ARTICLE
Antonio Luca Spiezia, Giulia Scalia, Maria Petracca, Daniele Caliendo, Marcello Moccia, Antonia Fiore, Vincenza Cerbone, Roberta Lanzillo, Vincenzo Brescia Morra, Antonio Carotenuto
BACKGROUND: Circulating immune cells play a pathogenic role in multiple sclerosis (MS). However, the role of specific lymphocyte subpopulations is not unveiled yet, especially in progressive stages. We aimed to investigate lymphocyte changes during siponimod treatment in active secondary progressive MS (aSPMS) and their associations with clinical outcomes. METHODS: We enrolled 46 aSPMS patients starting on siponimod treatment with at least 6 months of follow-up and two visits within the scheduled timeframes and 14 sex- and age-matched healthy controls (HCs)...
April 17, 2024: Journal of Neurology
https://read.qxmd.com/read/38631854/autopsy-case-of-meningoencephalitis-induced-by-nivolumab-and-ipilimumab-in-a-patient-being-treated-for-non-small-cell-lung-cancer
#25
JOURNAL ARTICLE
Keisuke Shiraha, Hiromi Watanabe, Keiichi Fujiwara, Mayu Goda, Tomoyoshi Inoue, Miho Fujiwara, Suzuka Matsuoka, Yuki Takigawa, Sho Mitsumune, Kenichiro Kudo, Akiko Sato, Ken Sato, Yoko Shinno, Takuo Shibayama
A 75-year-old woman with stage IVB (cT2bN3M1b) lung adenocarcinoma was administered nivolumab, ipilimumab, carboplatin, and paclitaxel. Fourteen days after receiving chemotherapy, she experienced an impaired consciousness and a cerebrospinal fluid analysis revealed high protein levels and pleocytosis. She was diagnosed with nivolumab- and ipilimumab-induced encephalitis and was treated with corticosteroids which were tapered to 10 mg/day, with no symptom recurrence. She died 18 weeks after the initial presentation, as the cancer worsened...
April 16, 2024: Internal Medicine
https://read.qxmd.com/read/38631714/efficacy-of-lcmv-based-cancer-immunotherapies-is-unleashed-by-intratumoral-injections-of-polyi-c
#26
JOURNAL ARTICLE
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
BACKGROUND: Lymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and humans. LCMV has been engineered for the development of cancer immunotherapies, currently undergoing evaluation in phase I/II clinical trials. Initial findings have demonstrated safety and an exceptional ability to activate and expand tumor-specific T lymphocytes. Combination strategies to maximize the antitumor effectiveness of LCMV-based immunotherapies are being explored...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631710/b-cells-and-the-coordination-of-immune-checkpoint-inhibitor-response-in-patients-with-solid-tumors
#27
REVIEW
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucia Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, Francois-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
Immunotherapy profoundly changed the landscape of cancer therapy by providing long-lasting responses in subsets of patients and is now the standard of care in several solid tumor types. However, immunotherapy activity beyond conventional immune checkpoint inhibition is plateauing, and biomarkers are overall lacking to guide treatment selection. Most studies have focused on T cell engagement and response, but there is a growing evidence that B cells may be key players in the establishment of an organized immune response, notably through tertiary lymphoid structures...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631709/preclinical-evaluation-of-two-phylogenetically-distant-arenavirus-vectors-for-the-development-of-novel-immunotherapeutic-combination-strategies-for-cancer-treatment
#28
JOURNAL ARTICLE
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
BACKGROUND: Engineered arenavirus vectors have recently been developed to leverage the body's immune system in the fight against chronic viral infections and cancer. Vectors based on Pichinde virus (artPICV) and lymphocytic choriomeningitis virus (artLCMV) encoding a non-oncogenic fusion protein of human papillomavirus (HPV)16 E6 and E7 are currently being tested in patients with HPV16+ cancer, showing a favorable safety and tolerability profile and unprecedented expansion of tumor-specific CD8+ T cells...
April 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631706/tumor-targeted-therapy-with-braf-inhibitor-recruits-activated-dendritic-cells-to-promote-tumor-immunity-in-melanoma
#29
JOURNAL ARTICLE
Florian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Ausserhofer, Christoph H Tripp, Sophie Dieckmann, Markus Kanduth, Kathryn Farrand, Sarah Bregar, Niloofar Nemati, Natascha Hermann-Kleiter, Athanasios Seretis, Sudhir Morla, David Mullins, Francesca Finotello, Zlatko Trajanoski, Guido Wollmann, Franca Ronchese, Marc Schmitz, Ian F Hermans, Patrizia Stoitzner
BACKGROUND: Tumor-targeted therapy causes impressive tumor regression, but the emergence of resistance limits long-term survival benefits in patients. Little information is available on the role of the myeloid cell network, especially dendritic cells (DC) during tumor-targeted therapy. METHODS: Here, we investigated therapy-mediated immunological alterations in the tumor microenvironment (TME) and tumor-draining lymph nodes (LN) in the D4M.3A preclinical melanoma mouse model (harboring the V-Raf murine sarcoma viral oncogene homolog B (BRAF)V600E mutation) by using high-dimensional multicolor flow cytometry in combination with multiplex immunohistochemistry...
April 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631594/single-cell-sequencing-reveals-distinct-immune-cell-features-in-cutaneous-lesions-of-pemphigus-vulgaris-and-bullous-pemphigoid
#30
JOURNAL ARTICLE
Zhi Hu, Meiling Zheng, Ziyu Guo, Wenhui Zhou, Wenyu Zhou, Nan Yao, Guiying Zhang, Qianjin Lu, Ming Zhao
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are two common subtypes of autoimmune bullous disease (AIBD). The key role of circulating autoreactive immune cells contributing to skin damage of AIBD has been widely recognized. Nevertheless, the immune characteristics in cutaneous lesions remain unclear. Here, we performed single-cell RNA sequencing (scRNA-seq) and single-cell VDJ sequencing (scRNA-seq) to generate transcriptional profiles for cells and T/B cell clonetype in skin lesions of BP and PV. We found that the proportions of NK&T, macrophages/ dendritic cells, B cells, and mast cells increased in BP and PV lesions...
April 15, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38631323/serum-levels-of-the-steroid-hormone-dehydroepiandrosterone-dhea-are-associated-with-psychological-trauma-and-lymphocyte-telomere-integrity-in-women-suffering-from-depression
#31
JOURNAL ARTICLE
Karin de Punder, Juan Salinas-Manrique, Detlef E Dietrich, Alexander Karabatsiakis
INTRODUCTION: Emerging studies highlight the telomere system as an aging mechanism underlying the association between exposure to psychological trauma and the development of a wide range of physical and mental disorders, including major depressive disorder (MDD). Here, we investigated associations of circulating levels of the steroid hormone dehydroepiandrosterone (DHEA) with immune cell telomere length (TL) in the context of lifetime trauma exposure and MDD. METHODS: Lifetime traumatic events (trauma load) were assessed using the Essener Trauma Inventory (ETI) in n=22 postmenopausal female inpatients with MDD and n=22 non-depressed controls...
April 17, 2024: Neuroimmunomodulation
https://read.qxmd.com/read/38631019/orchestrated-codelivery-of-peptide-antigen-and-adjuvant-to-antigen-presenting-cells-by-using-an-engineered-chimeric-peptide-enhances-antitumor-t-cell-immunity
#32
JOURNAL ARTICLE
Haifeng Pan, Siyuan Yu, Haoyun Zhuang, Han Yang, Jinlu Jiang, Haihui Yang, Shuling Ren, Guoxing Luo, Xuan Yu, Shuping Chen, Yanhua Lin, Roufang Sheng, Shiyin Zhang, Quan Yuan, Chenghao Huang, Tianying Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia
The intrinsic pharmacokinetic limitations of traditional peptide-based cancer vaccines hamper effective cross-presentation and codelivery of antigens and adjuvants, which are crucial for inducing robust antitumor CD8+ T-cell responses. Here, we report the development of a versatile strategy that simultaneously addresses the different pharmacokinetic challenges of soluble subunit vaccines composed of antigens and CpG to modulate vaccine efficacy via translating an engineered chimeric peptide, eTAT, as an intramolecular adjuvant...
April 17, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38630978/immunogenic-material-vaccine-for-cancer-immunotherapy-by-structure-dependent-immune-cell-trafficking-and-modulation
#33
JOURNAL ARTICLE
Wei Yang, Jianwei Cao, Sichen Di, Wenjin Chen, Hui Cheng, Hongze Ren, Yujie Xie, Liang Chen, Meihua Yu, Yu Chen, Xingang Cui
Inherently immunogenic materials offer enormous prospects in enhancing vaccine efficacy. However, the understanding and improving material adjuvanticity remain elusive. Herein we report how the structural presentation of immunopotentiators in a material governs the dynamic dialogue between innate and adaptive immunity for enhanced cancer vaccination. We precisely manipulate the immunopotentiator manganese into six differing structures that resemble the architectures of two types of pathogens (spherical viruses or rod-like bacteria)...
April 17, 2024: Advanced Materials
https://read.qxmd.com/read/38630781/safety-pharmacokinetics-pharmacodynamics-and-antitumor-activity-from-a-phase-i-study-of-simlukafusp-alfa-fap-il2v-in-advanced-metastatic-solid-tumors
#34
JOURNAL ARTICLE
Neeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg, Morten Mau-Sørensen, Debbie Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodriguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero
PURPOSE: Simlukafusp alfa (FAP-IL2v), a tumor-targeted immunocytokine, comprising an interleukin-2 variant moiety with abolished CD25 binding fused to human immunoglobulin G1, is directed against fibroblast activation protein-α. This phase I, open-label, multicenter, dose-escalation and extension study (NCT02627274) evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of FAP-IL2v in patients with advanced/metastatic solid tumors. METHODS: Participants received FAP-IL2v intravenously once weekly...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38630321/clinical-impact-of-transient-lymphopenia
#35
JOURNAL ARTICLE
Luigi Petramala, Cinzia Milito, Francesca Sarlo, Adriana Servello, Francesco Circosta, Luca Marino, Germano Sardella, Piero Trapani, Giulio D'aguanno, Antonino Cimo', Gioacchino Galardo, Claudio Letizia
Transient or persistent immunosuppression is a known risk factor for morbidity and mortality in critically ill patients. Aim of the present study is to evaluate the lymphopenia in patients admitted to the Emergency Unit of AOU Policlinico Umberto I, to investigate its prevalence at admission and the persistence during hospitalization until discharge. Possible correlations were evaluated between lymphopenia, diagnosis of admission, comorbidities and chronic treatments. In this study, 240 patients (142 men; 98 female; mean age 75...
April 17, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38630304/tlr5-agonist-in-combination-with-anti-pd-1-treatment-enhances-anti-tumor-effect-through-m1-m2-macrophage-polarization-shift-and-cd8-t-cell-priming
#36
JOURNAL ARTICLE
Junseok Lee, Keon-Il Im, Sojin Gil, Hyemin Na, Gi-June Min, Nayoun Kim, Seok-Goo Cho
Immune checkpoint inhibitors have revolutionized anti-tumor therapy, notably improving treatment responses in various tumors. However, many patients remain non-responsive and do not experience benefits. Given that Toll-like receptors (TLRs) can counteract tumor immune tolerance by stimulating both innate and adaptive immune responses, TLR agonists are being explored as potential immune adjuvants for cancer treatment. In this study, we assessed the potential of enhancing the efficacy of immune checkpoint inhibitors by activating innate immunity with a TLR5 agonist...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630291/comparative-performance-of-scfv-based-anti-bcma-car-formats-for-improved-t-cell-therapy-in-multiple-myeloma
#37
JOURNAL ARTICLE
Sophia Stock, Luisa Fertig, Adrian Gottschlich, Janina Dörr, Florian Märkl, Lina Majed, Vivien D Menkhoff, Ruth Grünmeier, Kai Rejeski, David M Cordas Dos Santos, Sebastian Theurich, Michael von Bergwelt-Baildon, Stefan Endres, Marion Subklewe, Sebastian Kobold
In multiple myeloma (MM), B cell maturation antigen (BCMA)-directed CAR T cells have emerged as a novel therapy with potential for long-term disease control. Anti-BCMA CAR T cells with a CD8-based transmembrane (TM) and CD137 (41BB) as intracellular costimulatory domain are in routine clinical use. As the CAR construct architecture can differentially impact performance and efficacy, the optimal construction of a BCMA-targeting CAR remains to be elucidated. Here, we hypothesized that varying the constituents of the CAR structure known to impact performance could shed light on how to improve established anti-BCMA CAR constructs...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630265/expansion-of-tumor-infiltrating-lymphocytes-from-head-and-neck-squamous-cell-carcinoma-to-assess-the-potential-of-adoptive-cell-therapy
#38
JOURNAL ARTICLE
Sangjoon Choi, Mofazzal Hossain, Hyun Lee, Jina Baek, Hye Seon Park, Chae-Lyul Lim, DoYeon Han, Taehyun Park, Jong Hyeok Kim, Gyungyub Gong, Mi-Na Kweon, Hee Jin Lee
BACKGROUND: Adoptive transfer of in vitro expanded tumor-infiltrating lymphocytes (TILs) has been effective in regressing several types of malignant tumors. This study assessed the yield and factors influencing the successful expansion of tumor-infiltrating lymphocytes (TILs) from head and neck squamous cell carcinoma (HNSCC), along with their immune phenotypes. METHODS: TILs were expanded from 47 surgically resected HNSCC specimens and their metastasized lymph nodes...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38629454/dna-methylation-based-telomere-length-is-associated-with-hiv-infection-physical-frailty-cancer-and-all-cause-mortality
#39
JOURNAL ARTICLE
Xiaoyu Liang, Bradley E Aouizerat, Kaku So-Armah, Mardge H Cohen, Vincent C Marconi, Ke Xu, Amy C Justice
Telomere length (TL) is an important indicator of cellular aging. Shorter TL is associated with several age-related diseases including coronary heart disease, heart failure, diabetes, osteoporosis, and cancer. Recently, a DNA methylation-based TL (DNAmTL) estimator has been developed as an alternative method for directly measuring TL. In this study, we examined the association of DNAmTL with cancer prevalence and mortality risk among people with and without HIV in the Veterans Aging Cohort Study Biomarker Cohort (VACS, N = 1917) and Women's Interagency HIV Study Cohort (WIHS, N = 481)...
April 17, 2024: Aging Cell
https://read.qxmd.com/read/38629410/comprehensive-evaluation-of-immune-dysregulation-in-secondary-hemophagocytic-lymphohistiocytosis
#40
JOURNAL ARTICLE
Yun Wang, Xu Yuan, Ting Wang, Wei Wei, Shiji Wu, Hongyan Hou
Host immune dysfunction plays a crucial role in the onset, progression, and outcome of hemophagocytic lymphohistiocytosis (HLH). This study aimed to comprehensively evaluate the peripheral immune profiles in patients with newly diagnosed secondary hemophagocytic lymphohistiocytosis (sHLH), and explore their predictive value for patient prognosis. A total of 77 patients with sHLH were enrolled in this study, with 31 of them experiencing mortality. Flow cytometry was used to assess the percentages, absolute numbers, and phenotypes of lymphocyte subsets...
December 2024: Virulence
keyword
keyword
8563
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.